Hims & Hers Health Stock Rallies on Regulatory Pivot. It’s Not About GLP-1s This Time.

Barrons — Apr 16, 12:46 PM

Hims has signaled its interest in peptides, many of which have been banned for use in compounding pharmacies.

Read full article at Barrons →

Hims & Hers Rallies on Peptides

RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves CNBC — Apr 16, 17:44 PM
How RFK Jr. Sent Hims & Hers Stock Higher Barrons — Apr 16, 12:46 PM
Hims rises as FDA considers broader peptides access; analysts see long-term win - Reuters Reuters — Apr 16, 15:35 PM